Table 2.
Variable | OR | 95% CI | P-value |
---|---|---|---|
Age at Diagnosis | 1.12 | 0.52–2.46 | 0.762 |
Sex (M:F) | 2.22 | 0.75–6.56 | 0.150 |
Radiotherapy | |||
Total dose (cGy) | |||
4005:5000 | 10.60 | 0.60–186.5 | 0.107 |
5400:5000 | 2.09 | 0.69–5.55 | 0.166 |
6000:5000 | 11.35 | 0.50–256.8 | 0.127 |
Tumour Location (vs ONS) | |||
CS | 0.41 | 0.048–3.56 | 0.417 |
IF | 1.58 | 0.22–11.48 | 0.650 |
ST | 1.69 | 0.24–11.87 | 0.598 |
GTV (cm3) | |||
Per 10 cm3 increase in GTV | 1.71 | 1.27–2.30 | 3.90 × 10−4 |
*p < 0.05 Wald test; RT- radiotherapy; Gy- gray; GTV- gross tumour volume; WHO- World Health Organization; fRT- fractionated radiotherapy.